Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3TLM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,661
Award facts
- Contract value 100% obligated
- $11,660.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,660.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml quantities, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of January 14, 2026. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open competition. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems.
This delivery order was executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains. This particular order for Ozempic, a diabetes management medication, exemplifies the breadth of pharmaceutical products the contractor delivers to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F3TLM?
SPE2DR26F3TLM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F3TLM worth?
The government has obligated $11,661 on SPE2DR26F3TLM.
Is contract SPE2DR26F3TLM an order under another contract?
Yes. SPE2DR26F3TLM is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TLM competed?
The extent of competition for SPE2DR26F3TLM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award